Total Payments
$3,858
2024 Payments
$1,728
Companies
20
Transactions
164
Medicare Patients
6,189
Medicare Billing
$479,322
Payment Breakdown by Category
Food & Beverage$3,754 (97.3%)
Education$104.08 (2.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,754 | 162 | 97.3% |
| Education | $104.08 | 2 | 2.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,165 | 56 | $0 (2024) |
| Janssen Biotech, Inc. | $1,151 | 44 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $504.13 | 22 | $0 (2024) |
| Incyte Corporation | $314.63 | 12 | $0 (2024) |
| LEO Pharma Inc. | $147.96 | 6 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $116.17 | 4 | $0 (2024) |
| Dermavant Sciences, Inc. | $64.19 | 3 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $59.56 | 3 | $0 (2024) |
| Amgen Inc. | $54.00 | 2 | $0 (2024) |
| Galderma Laboratories, L.P. | $37.20 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,728 | 70 | Janssen Biotech, Inc. ($649.85) |
| 2023 | $1,480 | 65 | Janssen Biotech, Inc. ($345.40) |
| 2022 | $538.18 | 24 | ABBVIE INC. ($285.66) |
| 2021 | $111.73 | 5 | AbbVie Inc. ($87.57) |
All Payment Transactions
164 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $32.94 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $29.51 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $27.82 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.53 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $31.53 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $27.45 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $28.17 | General |
| Category: Immunology | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $23.93 | General |
| Category: Immunology | ||||||
| 11/08/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $2.79 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: Dermatology | ||||||
| 11/06/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $36.92 | General |
| Category: Immunology | ||||||
| 11/06/2024 | MIMEDX Group, Inc. | — | Food and Beverage | In-kind items and services | $24.98 | General |
| 11/05/2024 | Organon Llc | — | Food and Beverage | In-kind items and services | $24.17 | General |
| 10/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.20 | General |
| Category: IMMUNOLOGY | ||||||
| 10/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $2.10 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.96 | General |
| Category: IMMUNOLOGY | ||||||
| 10/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $33.90 | General |
| Category: Immunology | ||||||
| 10/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: IMMUNOLOGY | ||||||
| 09/26/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $32.10 | General |
| Category: IMMUNOLOGY | ||||||
| 09/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $29.96 | General |
| Category: Immunology | ||||||
| 09/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.11 | General |
| Category: IMMUNOLOGY | ||||||
| 09/19/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $32.33 | General |
| Category: Immunology | ||||||
| 09/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.59 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,487 | 2,755 | $638,319 | $109,507 |
| 2022 | 13 | 1,572 | 2,962 | $491,214 | $115,463 |
| 2021 | 13 | 1,531 | 3,057 | $414,372 | $124,136 |
| 2020 | 15 | 1,599 | 2,918 | $438,297 | $130,215 |
Total Patients
6,189
Total Services
11,692
Medicare Billing
$479,322
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 471 | 742 | $224,826 | $39,833 | 17.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 198 | 245 | $96,040 | $15,874 | 16.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 247 | 385 | $103,950 | $13,149 | 12.6% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 25 | 32 | $21,600 | $9,746 | 45.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 76 | 89 | $39,694 | $6,675 | 16.8% |
| 96574 | Application of light with debridement to destroy precancer skin growth | Office | 2023 | 25 | 32 | $32,416 | $5,538 | 17.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 107 | 128 | $24,314 | $4,721 | 19.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 70 | 119 | $25,704 | $4,130 | 16.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 175 | 886 | $31,896 | $3,966 | 12.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 37 | 37 | $15,503 | $2,336 | 15.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 17 | 20 | $8,640 | $1,532 | 17.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 24 | 24 | $7,464 | $1,177 | 15.8% |
| 69100 | Biopsy of ear | Office | 2023 | 15 | 16 | $6,272 | $831.36 | 13.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 465 | 733 | $166,184 | $39,077 | 23.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 226 | 288 | $79,294 | $18,415 | 23.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 267 | 422 | $78,474 | $14,762 | 18.8% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2022 | 26 | 31 | $23,415 | $9,334 | 39.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 93 | 112 | $35,522 | $8,345 | 23.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 82 | 151 | $21,525 | $5,458 | 25.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 124 | 149 | $21,069 | $5,193 | 24.6% |
| 96574 | Application of light with debridement to destroy precancer skin growth | Office | 2022 | 25 | 29 | $20,228 | $5,060 | 25.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 181 | 959 | $20,294 | $4,514 | 22.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 43 | 43 | $12,493 | $2,688 | 21.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 15 | 19 | $5,582 | $1,565 | 28.0% |
| 69100 | Biopsy of ear | Office | 2022 | 12 | 13 | $4,356 | $634.41 | 14.6% |
About Mark Trott, PA
Mark Trott, PA is a Physician Assistant healthcare provider based in Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1205892924.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mark Trott, PA has received a total of $3,858 in payments from pharmaceutical and medical device companies, with $1,728 received in 2024. These payments were reported across 164 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($3,754).
As a Medicare-enrolled provider, Trott has provided services to 6,189 Medicare beneficiaries, totaling 11,692 services with total Medicare billing of $479,322. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Other Specialties Medical, Physician Assistant
- Location Providence, RI
- Active Since 04/21/2006
- Last Updated 02/28/2008
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1205892924
Products in Payments
- TREMFYA (Drug) $965.98
- SKYRIZI (Biological) $637.27
- Sotyktu (Drug) $477.59
- RINVOQ (Biological) $472.17
- OPZELURA (Drug) $314.63
- REMICADE (Biological) $184.87
- ADBRY (Biological) $147.96
- DUPIXENT (Biological) $143.78
- VTAMA (Drug) $64.19
- HUMIRA (Biological) $55.62
- Otezla (Drug) $54.00
- Winlevi (Drug) $42.55
- Bimzelx (Biological) $35.77
- COSENTYX (Drug) $27.82
- TALTZ (Drug) $24.75
- AKLIEF (Drug) $22.32
- YCANTH (Drug) $21.45
- PURIFIED CORTROPHIN GEL (Drug) $21.25
- AMELUZ (Drug) $19.71
- BLU-U (Medical Supply) $17.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Providence
Mr. Thomas Bales, Pa-C, PA-C
Physician Assistant — Payments: $17,581
Physician Assistant $17,581
Mrs. Amanda Matteson, Pa-C, PA-C
Physician Assistant — Payments: $8,188
Physician Assistant $8,188
Paige Lovelace, Pa-C, PA-C
Physician Assistant — Payments: $6,850
Physician Assistant $6,850
James Noon
Physician Assistant — Payments: $5,562
Physician Assistant $5,562
Helen Nguyen, Pa-C, PA-C
Physician Assistant — Payments: $4,500
Physician Assistant $4,500
Jessica Hitte, Pa-C, PA-C
Physician Assistant — Payments: $3,530
Physician Assistant $3,530